Starpharma VivaGel® BV secures TGA approval for prevention of BV
8 October 2020 Release date: 25 September 2020 Highlights: VivaGel® BV approved claims in Australia have been expanded to also include prevention of recurrent bacterial vaginosis (BV) VivaGel® BV is the only OTC pharmacy product in Australia to…
4DMedical Receives TGA Approval For XV Lung Ventilation Analysis Software (XV LVAS)
8 October 2020 Release date: 30 September 2020 Highlights The Australian Therapeutic Goods Administration (TGA) has approved 4DMedical’s XV Lung Ventilation Analysis Software (XV LVAS) for inclusion in the Australian Register of Therapeutic Goods (ARTG) XV LVAS utilises…
Tricycle Developments love to solve problems that improve lives and create positive impact
Posted 8 October 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. Tricycle Developments love to solve problems that improve lives and create a positive impact. Located in Melbourne, Tricycle provides design and…
RMIT research confirms link between sleep apnea and Alzheimer’s disease
8 October 2020 Release date 29 September 2020 New research led by RMIT University has confirmed long-suspected links between sleep apnea and Alzheimer’s disease, finding identical signs of brain damage in both conditions. While the cause of Alzheimer’s…
Epilepsy diagnosis fast-tracked with Monash machine learning technology
8 October 2020 Release date: 25 September 2020 Researchers at Monash University have applied advanced machine learning technology to provide epilepsy patients with a more accurate and rapid diagnosis. Together with Alfred Health and The Royal Melbourne hospital,…
Neurological consequences of COVID-19: The ‘Silent Wave’
8 October 2020 Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience…
WEHI researchers taking the STING out of MND
8 October 2020 Walter and Eliza Hall Institute researchers are working towards a potential treatment to slow the progression of motor neuron disease (MND), offering hope to people with this debilitating and incurable illness. The research team have…
MTPConnect release second edition of COVID-19 Impact Report
8 October 2020 Via MTPConnect With Australia confirming its first case of the coronavirus on 25 January 2020, it wasn’t long before COVID-19, the disease caused by SARS-CoV-2, emerged as a public health and economic crisis. The medical…
St Vincent’s Hospital on the Park leads new charge in Victoria’s collective fight against COVID-19
Posted 24 September 2020 This is a BioMelbourne Network Good News Story – click here to find out more and submit yours. St Vincent’s has welcomed patients at its newest hospital to help manage the escalating demand on…
Metro Tunnel Portrait Project Showcases Faces Behind Parkville Biomedical Precinct
24 September 2020 View the full article via Metro Tunnel. The Parkville Biomedical Precinct is home to some of the world’s leading medical researchers, clinicians and academics. Through 30 Precinct Partners, it delivers outstanding clinical care and education,…
Australia’s first Antimicrobial Resistance Network forms to combat global health threat
24 September 2020 MTPConnect today announced the formation of an Australian-first network bringing together key stakeholders to address the impact of antimicrobial resistance (AMR) on human health. The Australian Antimicrobial Resistance network – AAMRNet – has been established…
The Florey partners in multi-institute Mental Health PhD Program
Date posted 22 September 2020 The Florey Institute of Neuroscience and Mental Health will share responsibility for shaping and steering the University of Melbourne’s Mental Health PhD program with the Centre for Mental Health, the Department of Psychiatry,…
